Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

This session examines Saudi Arabia’s value proposition as a regional manufacturing hub for healthcare and medical ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

VanEck Biotech ETF gets a Hold rating as top holdings face low growth, patent cliffs, and rich valuation vs. peers. Click to read my latest analysis of BBH.

A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...

Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics.

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

We all know someone waiting on a medical breakthrough. It could be a parent battling a chronic illness, a colleague pushing ...

A facility that manufactures products for pharmaceutical companies is set to eliminate one of its two Massachusetts ...